2nd Quarter - Report

AMERICAN KIDNEY FUND for AMERICAN KIDNEY FUND

Firm
Client
Income
—
Expenses
$240,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Access to Genetic Counselor Services Act: H.R. 6280, S. 3607 Living Donor Protection Act: H.R. 4582, H.R 4583, S. 1552 Appropriations-NIH, NIDDK, Kidney Research The New Era for Preventing End-Stage Kidney Disease Act of 2025: H.R. 1518. Restore Protections for Dialysis Patients Act: H.R. 2199; S. 1173. Permanent OPTN Fee Authority Act: H.R.5259; S. 2751. Kidney Care Access Protection Act: S.2730. H.R. 6214 Expanding Support for Living Donors Act: H.R. 7868 Improving Home Dialysis Act: H.R. 8875 Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (CMS-4212-P) Request for Information: Opportunities, Challenges, and Emerging Areas in Statistical Data, Analysis, and Research

LobbyistCovered position, as disclosed
HOLLY A. BODE —
DEBORAH DARCY —
SCOTT MOORE New —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1173 (119th), H.R. 4582 (119th), H.R. 4583 (119th), H.R. 6280 (119th), H.R. 6214 (119th), H.R. 1518 (119th), H.R. 2199 (119th), S. 1552 (119th), S. 2730 (119th), S. 2751 (119th), H.R. 5259 (119th), H.R. 8875 (119th), H.R. 7868 (119th), S. 3607 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.